Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for Preventing Cardiovascular Disease and Diabetes in High Cardiometabolic Risk
NCT05749874Phase 4Active, not recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of berberine in cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), sponsored by National Center for Cardiovascular Disease. Started Oct 2023; status: active, not recruiting.
02
Drugs
berberine
03
Conditions
cardiovascular disease (CVD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05749874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749874.